Details
-
Change Request
-
Resolution: Persuasive
-
Low
-
US C-CDA on FHIR (FHIR)
-
1.2.0-ballot
-
Cross-Group Projects
-
STU
-
CF-medication
-
C-CDA to FHIR Medications
-
-
Jay Lyle/John D'Amore: 16-0-6
-
Clarification
-
Non-substantive
Description
Suggest removing maxDoseQuantity mapping for the typical reasons:
- No vendors demonstrated this mapping
- It's not required (or even well-explained) in C-CDA
- It's not required in US Core
Additionally, it's not clear (to me) what the field in CDA represents. Perhaps a definition exists deep in the RIM, but the C-CDA examples task force has never examplified this field, and there seem to be 3 potential candidates in FHIR for this data (maxDosePerPeriod, maxDosePerAdministration, maxDosePerLifetime)
Attachments
Issue Links
- is voted on by
-
BALLOT-49302 Negative - Benjamin Flessner : 2023-May-FHIR IG CCDA R1 STU
- Withdrawn
-
BALLOT-49470 Negative - Mike Paetz : 2023-May-FHIR IG CCDA R1 STU
- Balloted
-
BALLOT-49521 Negative - Nick Hatt : 2023-May-FHIR IG CCDA R1 STU
- Balloted
-
BALLOT-49581 Negative - Matthew Moore : 2023-May-FHIR IG CCDA R1 STU
- Balloted